Abstract

The prior International Breast Cancer Intervention Study I (IBIS-I) showed that, after a median follow-up of 8 years, tamoxifen reduced the risk for

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call